Patent · US Active

CEACAM based antibacterial agents

US11433113B2 · kind B2 · utility

1Cited by
7References
3Claims
0Family size

Inventor

Key dates

Filing dateAug 6, 2020
Grant dateSep 6, 2022
Priority date—
Expiry dateAug 6, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Prophylactic and/or therapeutic antipathogen agents are provided that disrupt or prevent the formation of at least one homotypic and/or heterotypic protein-protein interaction that has at least one CEA-family protein and that is involved in the establishment and colonization of a pathogen in a suitable host.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.